New Jersey Assembly Bill A2857

New Jersey 2024-2025 Regular Session

• Introduced: 1/9/24
• Refer: 1/9/24

Caption

Establishes insulin assistance program.

Impact

If enacted, A2857 will require the DHS to set up mechanisms for the reimbursement of pharmacies that dispense insulin products to eligible individuals. This program may ease the financial burden on individuals who cannot afford necessary medical supplies, potentially improving health outcomes for a vulnerable segment of the population. The implementation of this program indicates a shift in state law towards increasing support for uninsured residents and addressing healthcare inequities.

Summary

Assembly Bill A2857 proposes the establishment of an insulin assistance program under the Department of Human Services (DHS) in New Jersey. This program is designed to provide insulin and related supplies at no cost to 'qualified individuals', defined as those without health insurance who meet specific criteria. The bill emphasizes the importance of making essential diabetes supplies accessible to those facing financial hardships, and allows for a structured method of application and reapplication for those in need of assistance.

Contention

A key point of contention surrounding A2857 lies in the reliance on available funding for the program. While supporters argue that the bill represents critical support for those unable to afford insulin, critics express concerns about the program's sustainability and the potential limits of state resources. Additionally, discussions may arise regarding the adequacy of the reimbursement rates set for pharmacies, which could influence their willingness to participate in the program.